HSA — authorised 17 May 1962
- Marketing authorisation holder: PAR STERILE PRODUCTS
- Status: likely_approved
HSA authorised Coly-Mycin S on 17 May 1962
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 17 May 1962.
PAR STERILE PRODUCTS holds the Singaporean marketing authorisation.